RxDoctor Payments Data

Ashleigh Lucas

Nurse Practitioner · Winston Salem, NCNPI 1790266310

Payments from drug & device makers

$5,661in general payments, 2019–2025

Across 70 payments — averaging $80.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$2K
  • Globus Medical$333
  • AstraZeneca$217
  • SPR Therapeutics, Inc$210
  • Lilly USA, LLC$150
  • plus $424 from 4 others

What the payments were for

  • Travel & lodging$2,54345%
  • Food & beverage$3,11955%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,661 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,700
Medicare patients
215
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$17,404
EliquisApixaban17$15,837
RybelsusSemaglutide12$15,635
JanuviaSitagliptin Phosphate11$10,707
MyrbetriqMirabegron14$7,168
PaxlovidNirmatrelvir/Ritonavir19$2,736
Ventolin HfaAlbuterol Sulfate18$1,522
Losartan Potassium83$1,441
Levothyroxine Sodium65$1,026
Pravastatin Sodium41$971
Lisinopril65$958
Amlodipine Besylate130$900
Fluticasone Propionate43$865
Albuterol Sulfate HfaAlbuterol Sulfate26$757
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav73$686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$124$15,63512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →